| METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes OY Bello-Chavolla, P Almeda-Valdes, D Gomez-Velasco, T Viveros-Ruiz, ... European journal of endocrinology 178 (5), 533-544, 2018 | 238 | 2018 |
| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 187 | 2018 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 177 | 2021 |
| Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat JZ Lin, AJ Martagón, SL Cimini, DD Gonzalez, DW Tinkey, A Biter, ... Cell reports 13 (8), 1528-1537, 2015 | 120 | 2015 |
| Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations PR Shea, SB Beres, AR Flores, AL Ewbank, JH Gonzalez-Lugo, ... Proceedings of the National Academy of Sciences 108 (12), 5039-5044, 2011 | 108 | 2011 |
| Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002–2010 PR Shea, AL Ewbank, JH Gonzalez-Lugo, AJ Martagon-Rosado, ... Emerging infectious diseases 17 (11), 2010, 2011 | 91 | 2011 |
| Empowerment of patients with type 2 diabetes: current perspectives DV Gómez-Velasco, P Almeda-Valdes, AJ Martagón, GA Galán-Ramírez, ... Diabetes, metabolic syndrome and obesity: targets and therapy, 1311-1321, 2019 | 74 | 2019 |
| Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor JZ Lin, AJ Martagón, WA Hsueh, JD Baxter, JÅ Gustafsson, P Webb, ... Endocrinology 153 (12), 6136-6144, 2012 | 72 | 2012 |
| Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health OY Bello-Chavolla, NE Antonio-Villa, A Vargas-Vázquez, TL Viveros-Ruiz, ... Clinical nutrition 39 (5), 1613-1621, 2020 | 69 | 2020 |
| Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus M Ortiz-Martínez, M González-González, AJ Martagón, V Hlavinka, ... Current diabetes reports 22 (3), 95-115, 2022 | 56 | 2022 |
| Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study D Elías-López, A Vargas-Vázquez, R Mehta, I Cruz Bautista, ... BMC endocrine disorders 21 (1), 85, 2021 | 42 | 2021 |
| Prediction of incident hypertension and arterial stiffness using the non–insulin‐based metabolic score for insulin resistance (METS‐IR) index OY Bello‐Chavolla, NE Antonio‐Villa, A Vargas‐Vázquez, AJ Martagón, ... The Journal of Clinical Hypertension 21 (8), 1063-1070, 2019 | 41 | 2019 |
| The panorama of familial hypercholesterolemia in Latin America: a systematic review [S] R Mehta, R Zubiran, AJ Martagon, A Vazquez-Cardenas, Y Segura-Kato, ... Journal of lipid research 57 (12), 2115-2129, 2016 | 37 | 2016 |
| The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice AJ Martagón, JZ Lin, SL Cimini, P Webb, KJ Phillips PLoS One 10 (4), e0122987, 2015 | 37 | 2015 |
| The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes P Almeda-Valdes, DV Gómez Velasco, O Arellano Campos, ... European Journal of Endocrinology 180 (2), 99-107, 2019 | 24 | 2019 |
| Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk NE Antonio-Villa, OY Bello-Chavolla, A Vargas-Vázquez, R Mehta, ... Nutrition, Metabolism and Cardiovascular Diseases 31 (2), 506-517, 2021 | 22 | 2021 |
| The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes NE Antonio‐Villa, OY Bello‐Chavolla, A Vargas‐Vázquez, R Mehta, ... Diabetic Medicine 37 (7), 1192-1201, 2020 | 21 | 2020 |
| Familial hypercholesterolemia in Mexico: Initial insights from the national registry R Mehta, AJ Martagon, GAG Ramirez, NE Antonio-Villa, ... Journal of Clinical Lipidology 15 (1), 124-133, 2021 | 18 | 2021 |
| LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred R Mehta, D Elías-López, AJ Martagón, OA Pérez-Méndez, MLO Sánchez, ... Lipids in Health and Disease 20, 1-18, 2021 | 17 | 2021 |
| Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas AJ Martagón, OY Bello-Chavolla, O Arellano-Campos, P Almeda-Valdés, ... Diabetes Care 41 (8), 1726-1731, 2018 | 17 | 2018 |
